Biotech

West Announces Fourth Quarter and Full-Year 2015 Results

EXTON, PA: Reports Quarterly Sales of $359.7 Million and Adjusted Diluted EPS of $0.47 -- Annual Sales of $1.4 Billion Generated Adjusted Diluted EPS of $1.83 in 2015 -- Reaffirms 2016 Guidance for 6% to 8% Grow ...

Novaseek Research Wins Pistoia Alliance President''s Startup Challenge 2015

BOSTON, MA: ...

RepliCel Announces CEO Update

VANCOUVER, BRITISH COLUMBIA: Milestones for 2016 include two clinical trial readouts, finalizing RCI-02 for a 2017 product launch, and initiation of Shiseido's pattern baldness trial in Japan ...

Sernova Receives First Payment from the European Commission''s Horizon 2020 Grant to Fund Development of a Cell-Based Hemophilia Therapeutic Using the Cell Pouch(TM)

LONDON, ONTARIO: Payment represents the first non-dilutive installment to Sernova as consortium member from the ?5.6Million ($8.5 million CAD) HemAcure Grant Award ...

Theratechnologies to Announce Financial Results for Fiscal Year 2015

MONTREAL, QUEBEC: ...

ONL Therapeutics Receives Orphan Drug Designation for ONL1204 for Treatment of Retinal Detachment From FDA

ANN ARBOR, MI: ...

Theravance Biopharma Achieves 50% Enrollment in All Three Phase 3 Clinical Studies of Revefenacin (TD-4208) for Treatment of Chronic Obstructive Pulmonary Disease (COPD)

DUBLIN, IRELAND: 50% Enrollment Milestone in the Long-Term Safety Study Triggers $15 Million Payment to Theravance Biopharma From Mylan ...

Medgenics to Host Conference Call to Announce Fourth Quarter and Year End 2015 Financial Results

PHILADELPHIA, PA: ...

Sernova Honoured as Member of the "2016 TSX Venture 50" and Ranked #4 in Life Sciences and Clean Technologies

LONDON, ONTARIO: Sernova resides in the top 3% of TSX Venture Exchange Companies in market performance ...

Hemostemix Issues Corporate Update From CEO Elmar Burchardt

TORONTO, ONTARIO: ...